Trillium Therapeutics Inc. (TRIL.TO) has an overall financial health rating of B with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2022-02-09.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2022-02-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-02-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-01-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-11-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-11-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-11-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
